Gene expression profiling identifies potential biomarkers for vaso-occlusive episodes in sickle cell disease
JCI Insight · 09.03.2026 · 11 (5)
DOI: 10.1172/jci.insight.193359 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 09.03.2026. Verfasst von Varsha Bhat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Integrative Genomics, School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Vaso-Occlusive Crises. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Vaso-occlusive episodes (VOEs) or acute pain events, involving complex interactions between sickle erythrocytes and other blood cells, are a hallmark of sickle cell disease (SCD). In this study, we analyzed changes in peripheral blood transcriptomes between steady state and VOEs in individuals with SCD. We followed a cohort of 174 individuals with SCD with or without chronic pain and collected peripheral blood at clinic visits (steady state) and during hospitalizations (VOEs). We performed RNA-Seq profiling of CD45 + leukocytes and CD71 + erythroid cells. Pathways linked to complement activation, coagulation, and IL-6/JAK/STAT3 signaling were enriched during VOEs in the CD45 + cells. Contrastingly, the CD71 + cells showed an enrichment of pathways related to the cell cycle, such as mTORC1 signaling and the G 2 M checkpoint during VOEs. We then analyzed the expression changes of genes in patients with longitudinal data to determine potential biomarkers for VOEs. Expression of 4 genes — FAM20A , IL1B , MS4A4A , and SERPINB2 — was elevated during VOEs compared with steady state in the majority of patients. Furthermore, our results indicate that patients experiencing chronic pain exhibited 44% increased enrichment of significant pathways during VOEs when compared with patients without chronic pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Integrative Genomics, School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.
- Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
- Pfizer, South San Francisco, California, USA.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Bhat, V., Yoo, J. J., Ponna, S., Potdar, A. A., Patel, A. P., Yu, G. K., Gibson, G., & Sheehan, V. A. (2026). Gene expression profiling identifies potential biomarkers for vaso-occlusive episodes in sickle cell disease. JCI Insight, 11(5). https://doi.org/10.1172/jci.insight.193359
Vancouver
Bhat V, Yoo JJ, Ponna S, Potdar AA, Patel AP, Yu GK, et al. Gene expression profiling identifies potential biomarkers for vaso-occlusive episodes in sickle cell disease. JCI Insight. 2026;11(5). doi:10.1172/jci.insight.193359
BibTeX
@article{Bhat2026,
author = {Bhat, Varsha and Yoo, Justin J and Ponna, Srija and Potdar, Alka A and Patel, Ashwin P and Yu, G Karen and Gibson, Greg and Sheehan, Vivien A},
title = {Gene expression profiling identifies potential biomarkers for vaso-occlusive episodes in sickle cell disease},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {5},
doi = {10.1172/jci.insight.193359}
}
EUVIMED